Routine monitoring tests
| Mild disease severity | Moderate–severe | |
| Severity Index scoring | Baseline | Baseline |
| Body Mass Index | Annual | Annual |
| Exacerbation history | Annual | 6 monthly |
| Sputum culture | Annual | 6 monthly |
| MRC Dyspnoea Score | Annual | 6 monthly |
| Spirometry | Annual | Annual |
| CT (radiological extent) | At diagnosis*‡ | At diagnosis*‡ |
| Sputum mycobacterial culture† | Baseline‡ | Baseline‡ |
| Oxygen saturation monitoring (SpO2) | Annual | 6 monthly |
| Aetiological investigations | At diagnosis‡ | At diagnosis‡ |
| Comorbidities assessment | At diagnosis‡ | At diagnosis‡ |
*Consider repeat CT scanning in patients with primary immunodeficiency with scan interval of 3-5-years.
†This may need tailored in light of the local prevalence rates of NTM infections and in some centres may need undertaken on a regular basis. Further cultures at exacerbationmay be appropriate.
‡Repeat investigations if a deteriorating patient.
MRC, Medical Research Council.